Discover Water<\/a>, a water company performance data website which brings robust already-available company data from a range of sources together includes detail on sewer flooding incidents. In 2022-23; 47,176 areas of private land or gardens were flooded by sewage and 4,794 properties were internally flooded by sewage.<\/p> <\/p>
Sewer flooding may occur for a number of reasons, including a failure of the sewerage system; blockages; or when the sewerage system is overwhelmed when too much rainwater enters the sewers from surrounding roads, houses and land. Storm overflows stop sewage backing up into homes by releasing wastewater when the system is overwhelmed during periods of heavy rain. A growing population and ageing infrastructure, means these storm overflows are being pushed beyond their intended limits and that needs to change. As part of our Plan for Water, water companies are delivering the largest infrastructure programme in history - £60 billion of investment over 25 years. We continue to hold water companies to account and will not hesitate to act where there is evidence of wrongdoing.<\/p>
<\/p>
Government recognises the importance of having a robust drainage system both now and for future demand. As per commitments in the Environmental Improvement Plan and the Plan for Water, Defra will legislate to require water companies in England to produce Drainage and Wastewater Management Plans (DWMPs). DWMPs set out how a water company intends to improve their drainage and wastewater systems over the next 25 years, accounting for factors including growing population and changing environmental circumstances. When producing DWMPs, water companies will be required to identify solutions in collaboration with other partners such as lead local flood authorities (LLFAs) and other flood risk management authorities.<\/p>
<\/p>
Flooding from heavy rain and thunderstorms is known as surface water flooding. In England 3.4 million properties are at risk of such flooding. The responsibility for managing local flood risk, including from surface water, falls to LLFAs, in partnership with highways authorities and water companies. LLFAs are required to identify and agree local objectives for managing these local flood risks and to set them out in their statutory Local Flood Risk Management Strategy.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4861", "label" : {"_value" : "Biography information for Robbie Moore"}
}
, "answeringMemberConstituency" : {"_value" : "Keighley"}
, "answeringMemberPrinted" : {"_value" : "Robbie Moore"}
, "dateOfAnswer" : {"_value" : "2024-03-08", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-03-08T13:30:26.52Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "13"}
, "answeringDeptShortName" : {"_value" : "Environment, Food and Rural Affairs"}
, "answeringDeptSortName" : {"_value" : "Environment, Food and Rural Affairs"}
, "date" : {"_value" : "2024-02-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Sewage: Pollution"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Environment, Food and Rural Affairs, whether he has made an estimate of the number of homes affected by sewage rising into (a) gardens, (b) toilets and (c) sinks after heavy rains.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1591", "label" : {"_value" : "Biography information for Tim Farron"}
}
, "tablingMemberConstituency" : {"_value" : "Westmorland and Lonsdale"}
, "tablingMemberPrinted" : [{"_value" : "Tim Farron"}
], "uin" : "13955"}
, {"_about" : "http://data.parliament.uk/resources/1688963", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1688963/answer", "answerText" : {"_value" : "
The Department regularly discusses a range of issues with colleagues in NHS England and the National Institute for Health and Care Excellence (NICE), related to patient access to new treatments.<\/p>
<\/p>
The NICE appraises all new licensed medicines, and its recommendations are developed independently in line with its established methods and processes, on the basis of an assessment of the available evidence, and through extensive engagement with stakeholders. NHS England is legally required to fund treatments recommended in NICE technology appraisal guidance.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"}
}
, "answeringMemberConstituency" : {"_value" : "Pendle"}
, "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"}
, "dateOfAnswer" : {"_value" : "2024-02-21", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-02-21T16:13:28.647Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-02-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Blood Diseases: Medical Treatments"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions she has had with (a) NICE and (b) NHS England on encouraging the adoption of new treatments for (i) sickle cell disease and (ii) beta-thalassaemia.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/481", "label" : {"_value" : "Biography information for Sir George Howarth"}
}
, "tablingMemberConstituency" : {"_value" : "Knowsley"}
, "tablingMemberPrinted" : [{"_value" : "Sir George Howarth"}
], "uin" : "13899"}
, {"_about" : "http://data.parliament.uk/resources/1688964", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1688964/answer", "answerText" : {"_value" : "
Department officials regularly discuss a range of issues with colleagues in the National Institute for Health and Care Excellence (NICE) and HM Treasury. The NICE is responsible for the methods and processes it uses to develop its recommendations, and concluded a comprehensive review of the methods and processes it uses for health technology evaluation, in January 2022. The NICE carried out the review through extensive engagement with stakeholders, including officials within the Department. The NICE introduced a number of changes that make its methods fairer, faster, more consistent, and appropriate to the evaluation of emerging new technologies, such as cell and gene therapies.<\/p>
The NICE is monitoring the impact of the changes following the methods review and has committed to considering modular updates to its methods and processes in the future, including a planned update focussed on health inequalities in 2024. The NICE has been able to recommend several advanced therapeutic medicinal products, including one-off gene therapies, for National Health Service funding that are now available to NHS patients in line with NICE\u2019s recommendations.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"}
}
, "answeringMemberConstituency" : {"_value" : "Pendle"}
, "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"}
, "dateOfAnswer" : {"_value" : "2024-02-21", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "13901"}
, {"_value" : "13902"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-02-21T16:08:58.61Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-02-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "National Institute for Health and Care Excellence: Medical Treatments"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions she has had with NICE on developing its methodologies to ensure future access to (a) innovative one-time treatments and (b) cell and genetic therapies.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/481", "label" : {"_value" : "Biography information for Sir George Howarth"}
}
, "tablingMemberConstituency" : {"_value" : "Knowsley"}
, "tablingMemberPrinted" : [{"_value" : "Sir George Howarth"}
], "uin" : "13900"}
, {"_about" : "http://data.parliament.uk/resources/1688965", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1688965/answer", "answerText" : {"_value" : "
Department officials regularly discuss a range of issues with colleagues in the National Institute for Health and Care Excellence (NICE) and HM Treasury. The NICE is responsible for the methods and processes it uses to develop its recommendations, and concluded a comprehensive review of the methods and processes it uses for health technology evaluation, in January 2022. The NICE carried out the review through extensive engagement with stakeholders, including officials within the Department. The NICE introduced a number of changes that make its methods fairer, faster, more consistent, and appropriate to the evaluation of emerging new technologies, such as cell and gene therapies.<\/p>
The NICE is monitoring the impact of the changes following the methods review and has committed to considering modular updates to its methods and processes in the future, including a planned update focussed on health inequalities in 2024. The NICE has been able to recommend several advanced therapeutic medicinal products, including one-off gene therapies, for National Health Service funding that are now available to NHS patients in line with NICE\u2019s recommendations.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"}
}
, "answeringMemberConstituency" : {"_value" : "Pendle"}
, "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"}
, "dateOfAnswer" : {"_value" : "2024-02-21", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "13900"}
, {"_value" : "13902"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-02-21T16:08:58.67Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-02-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "National Institute for Health and Care Excellence: Medical Treatments"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions she has had with the (a) National Institute for Health and Care Excellence (NICE) and (b) Chancellor of the Exchequer on the application of NICE's evaluation methods to support value assessment for one-off curative treatments for which health gains are accrued over time.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/481", "label" : {"_value" : "Biography information for Sir George Howarth"}
}
, "tablingMemberConstituency" : {"_value" : "Knowsley"}
, "tablingMemberPrinted" : [{"_value" : "Sir George Howarth"}
], "uin" : "13901"}
, {"_about" : "http://data.parliament.uk/resources/1688966", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1688966/answer", "answerText" : {"_value" : "
Department officials regularly discuss a range of issues with colleagues in the National Institute for Health and Care Excellence (NICE) and HM Treasury. The NICE is responsible for the methods and processes it uses to develop its recommendations, and concluded a comprehensive review of the methods and processes it uses for health technology evaluation, in January 2022. The NICE carried out the review through extensive engagement with stakeholders, including officials within the Department. The NICE introduced a number of changes that make its methods fairer, faster, more consistent, and appropriate to the evaluation of emerging new technologies, such as cell and gene therapies.<\/p>
The NICE is monitoring the impact of the changes following the methods review and has committed to considering modular updates to its methods and processes in the future, including a planned update focussed on health inequalities in 2024. The NICE has been able to recommend several advanced therapeutic medicinal products, including one-off gene therapies, for National Health Service funding that are now available to NHS patients in line with NICE\u2019s recommendations.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4044", "label" : {"_value" : "Biography information for Andrew Stephenson"}
}
, "answeringMemberConstituency" : {"_value" : "Pendle"}
, "answeringMemberPrinted" : {"_value" : "Andrew Stephenson"}
, "dateOfAnswer" : {"_value" : "2024-02-21", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : [{"_value" : "13900"}
, {"_value" : "13901"}
], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-02-21T16:08:58.7Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2024-02-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "National Institute for Health and Care Excellence: Medical Treatments"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what discussions she has had with the National Institute for Health and Care Excellence on updates in the way that it assesses medicines that reduce health inequalities.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/481", "label" : {"_value" : "Biography information for Sir George Howarth"}
}
, "tablingMemberConstituency" : {"_value" : "Knowsley"}
, "tablingMemberPrinted" : [{"_value" : "Sir George Howarth"}
], "uin" : "13902"}
, {"_about" : "http://data.parliament.uk/resources/1688967", "AnsweringBody" : [{"_value" : "Church Commissioners"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1688967/answer", "answerText" : {"_value" : "
The National Church Institutions have an external NCIs Complaints Policy, which can be found on the Church of England website at: National Church Institutions | The Church of England<\/a>. A complaint is defined as any expression of dissatisfaction with the service offered by the NCIs to an individual or organisation, which could include an issue with the standard of service, a specific action taken (or not taken) or the behaviour of individuals working within or on behalf of the NCIs, in their interactions with the complainant. This could include the behaviour of NCI senior staff.<\/p>Complaints may come from any individual, volunteer or organisation directly involved with a specific matter being handled by the NCIs, including the general public, members of the clergy and staff in a church body.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/1453", "label" : {"_value" : "Biography information for Andrew Selous"}
}
, "answeringMemberConstituency" : {"_value" : "South West Bedfordshire"}
, "answeringMemberPrinted" : {"_value" : "Andrew Selous"}
, "dateOfAnswer" : {"_value" : "2024-02-26", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2024-02-26T21:41:44.197Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "9"}
, "answeringDeptShortName" : {"_value" : "Church Commissioners"}
, "answeringDeptSortName" : {"_value" : "Church Commissioners"}
, "date" : {"_value" : "2024-02-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Church of England: Staff"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Member for South West Bedfordshire, representing the Church Commissioners, what processes there are for complaints against senior staff of the National Church Institutions.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/230", "label" : {"_value" : "Biography information for Mr Ben Bradshaw"}
}
, "tablingMemberConstituency" : {"_value" : "Exeter"}
, "tablingMemberPrinted" : [{"_value" : "Mr Ben Bradshaw"}
], "uin" : "13865"}
, {"_about" : "http://data.parliament.uk/resources/1688968", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1688968/answer", "answerText" : {"_value" : "
The Department and NHS England do not centrally hold information on hospital acquired sepsis, although incidents of this may be held by local providers. The Office for National Statistics publishes the number of death registrations where sepsis is mentioned anywhere on the death certificate, in England and Wales. The following table shows the number of deaths registered where sepsis was mentioned anywhere on the death certificate in England and Wales, in each of the last ten years until 2022:<\/p>
<\/p>